China Biotech Services Holdings Ltd
08037
Company Profile
Business description
China Biotech Services Holdings Ltd is an investment holding company. It operates through five segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Insurance brokerage, BNCT and Others. It derives prime revenue from the Medical and health related services segment which involves the provision of medical laboratory testing and health check services. The group has a business presence in Hong Kong and the PRC, of which key revenue is generated from Hong Kong.
Contact
255-257 Gloucester Roaad
Suites 1904-05A, 19th Floor, Sino Plaza
Causeway Bay
Hong Kong
HKGT: +852 31883333
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
141
Stocks News & Analysis
stocks
ASX reporting season wrap: BHP, banks, CSL bloodbath and more
A round up of notable stories and reactions as ASX earnings season continues.
stocks
Stock showdown: How do ASX healthcare giants compare on key investing criteria?
Our healthcare analyst Shane Ponraj helps me compare the moatiness and growth prospects of two sector heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,234.30 | 55.70 | -0.60% |
| CAC 40 | 7,969.69 | 31.40 | 0.40% |
| DAX 40 | 24,363.09 | 69.75 | 0.29% |
| Dow JONES (US) | 45,631.74 | 846.24 | 1.89% |
| FTSE 100 | 9,321.40 | 12.20 | 0.13% |
| HKSE | 25,339.14 | 234.53 | 0.93% |
| NASDAQ | 21,496.54 | 396.22 | 1.88% |
| Nikkei 225 | 42,633.29 | 23.12 | 0.05% |
| NZX 50 Index | 13,042.76 | 151.31 | -1.15% |
| S&P 500 | 6,466.91 | 96.74 | 1.52% |
| S&P/ASX 200 | 8,967.40 | 57.00 | -0.63% |
| SSE Composite Index | 3,825.76 | 54.66 | 1.45% |